№ lp_1_2_27397
File format: docx
Character count: 37389
File size: 99 KB
This document provides detailed guidance on the use of Apomorphine injections for patients with advanced Parkinson’s disease in adult services within the NHS, covering treatment initiation, dose regimes, and specialist responsibilities.
Year:
2025
Region / city:
NENC
Document type:
Shared Care Protocol
Organization / institution:
NHS
Author:
NENC
Target audience:
NHS healthcare professionals
Period of validity:
Until December 2026
Approval date:
19th May 2025
Date of changes:
12th December 2024
Planned review date:
December 2026
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2023
Region / City:
Canberra
Document Type:
Medical procedure
Organization:
Canberra Health Services
Author:
Not specified
Target Audience:
Medical professionals, including Neurologists, Geriatricians, Nurses, Pharmacists, and Students under supervision
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Modifications:
Not specified
Year:
2026
Institution:
Nova Southeastern University, Ft. Lauderdale
Course:
Neuromuscular Systems II
Credits:
2
Duration:
12 weeks, first semester of third year
Contributors:
Suzana Simoes PT, DPT, NCS; Kim B. Smith PT, DPT; Jennifer Canbek, PT, PhD, NCS
Target audience:
Physical therapy students
Activity type:
Laboratory learning activity with volunteer patients
Focus:
Clinical decision making using ICF model for Parkinson’s disease
Learning objectives:
Assessment of PD cases, development of PT problem list, formulation of patient-centered plan of care, implementation of treatment interventions, evaluation of treatment outcomes
Materials:
Assigned readings from Schenkman & McCulloch (2002), Schenkman et al. (2010)
Methods:
Lab sessions with patient volunteers, outcome measures, treatment sessions, video documentation, SOAP note assignments
Assessment:
Rubric-based evaluation of outcome measures, ICF model application, problem list, plan of care, goals, treatment, and documentation
Year:
Not specified
Region / city:
Not specified
Theme:
Parkinson’s disease, therapeutic research
Document Type:
Pre-Clinical Proposal Template
Organization / Institution:
Michael J. Fox Foundation
Author:
Not specified
Period of validity:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
FREEZING OF GAIT (FOG) IN PARKINSON’S DISEASE RESEARCH PROGRAM Request for Applications Pre-Proposal
Note:
Year
Document type:
Research Program Request for Applications
Organization / institution:
MJFF
Target audience:
Researchers, clinicians, industry partners
Year:
2023
Region / city:
Cardiff, Blackwood
Topic:
Dance for Parkinson’s
Document Type:
Case Study
Organization / institution:
English National Ballet, National Dance Company Wales
Author:
University of Roehampton
Target Audience:
People living with Parkinson’s, healthcare professionals, dance enthusiasts
Duration:
Ongoing
Approval Date:
2011
Revision Date:
Not specified
Year:
2023
Region / City:
Canberra
Document Type:
Medical procedure
Organization:
Canberra Health Services
Author:
Not specified
Target Audience:
Medical professionals, including Neurologists, Geriatricians, Nurses, Pharmacists, and Students under supervision
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Modifications:
Not specified
Year:
Not specified
Region / city:
Not specified
Document Type:
Request for Applications
Organization / institution:
Not specified
Author:
Not specified
Target audience:
Researchers in Parkinson’s disease therapeutics
Period of validity:
Not specified
Approval date:
Not specified
Amendment date:
Not specified
Note:
Year
Document Type:
Research Proposal
Target Audience:
Researchers, Clinicians
Note:
Year
Topic:
Neurology, Parkinson’s Disease
Document Type:
Request for Applications
Year:
2018
Region / city:
London
Theme:
Dementia care, pharmacology
Document type:
Clinical guideline
Organization / institution:
London Dementia Clinical Network (NHS England and Improvement London Region)
Author:
Delia Bishara (Consultant Pharmacist, South London and Maudsley NHS Foundation Trust)
Target audience:
Healthcare professionals involved in dementia care
Effective period:
2018–present
Approval date:
Not specified
Date of amendments:
Not specified
Year:
2024
Region / city:
Australia
Document Type:
Medical Submission
Organization / Institution:
PBAC
Author:
Not specified
Target audience:
Medical practitioners, pharmaceutical authorities
Period of validity:
Not specified
Approval date:
Not specified
Amendment date:
November 2024
Note:
Context
Note:
Year
Theme:
Parkinson’s disease, Movement disorders
Document Type:
Supplementary Method
Target Audience:
Researchers, healthcare professionals
Year:
2017
Region / City:
California
Topic:
Parkinson’s Disease, Reporting Requirements
Document Type:
Implementation Guide
Organization / Institution:
California Department of Public Health
Author:
California State Senate
Target Audience:
Healthcare providers diagnosing or treating Parkinson’s disease patients
Effective Period:
July 1, 2018 and onwards
Approval Date:
July 2017
Modification Date:
Not specified
Note:
Year
Year:
2026
Region / City:
Devon
Subject:
Healthcare, Medical Services
Document Type:
Job Description
Organization / Institution:
Royal Devon & Exeter Hospital
Author:
Royal Devon & Exeter Hospital
Target Audience:
Healthcare professionals, applicants for the position
Effective Period:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2024
Region / City:
Chester
Document Type:
Newsletter
Author:
Nick Dent
Period of Validity:
February 2024
Approval Date:
February 2024
Date of Changes:
February 2024
Year:
2025
Region / City:
Australia
Topic:
Pharmaceutical submission for drug listing
Document Type:
Pharmaceutical submission
Organization:
Janssen-Cilag Pty Ltd
Author:
Not specified
Target Audience:
Healthcare professionals, regulatory authorities
Validity Period:
Not specified
Approval Date:
Not specified
Date of Changes:
March 2025
Note:
Context
Year:
2026
Region / City:
EMEA
Subject:
Pharmaceutical Information
Document Type:
Product Information
Organization / Institution:
European Medicines Agency
Author:
European Medicines Agency
Target Audience:
Healthcare Professionals, Medical Practitioners
Validity Period:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2023
Region / City:
Australia
Subject:
Chronic migraine, medicinal product submission
Document type:
Submission for PBS listing
Organization:
Novartis Pharmaceuticals Australia Pty. Limited
Author:
Not specified
Target audience:
Health professionals, pharmaceutical regulatory bodies
Period of validity:
Not specified
Date of approval:
2 July 2018
Date of amendments:
November 2023